Drugs.com - Pharma Industry News

FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy

TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).The new tablet is expected to be available in the...

Feb 18, 2025 - 18:49
 0
FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).The new tablet is expected to be available in the...
Read More

Tags:

Previous Article

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors

Next Article

ASA: Intra-Arterial Tenecteplase Beneficial for Large Vessel Occlusion

Related Posts

New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists

New Facial Plastic Surgery Survey Illustrates Impact of...

Feb 9, 2025  0

Risk of Developing Cancer Up for Children With Congenital Heart Disease

Risk of Developing Cancer Up for Children With Congenit...

Mar 18, 2025  0

Gastrointestinal Complications From Alcohol Increasing in Young People

Gastrointestinal Complications From Alcohol Increasing ...

Mar 5, 2025  0